Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
02:13:04 EDT Tue 07 May 2024
Enter Symbol
or Name
USA
CA



Orion Nutraceuticals Inc (2)
Symbol ORI
Shares Issued 27,784,557
Close 2020-07-28 C$ 0.40
Market Cap C$ 11,113,823
Recent Sedar Documents

Orion Nutra to issue 12,500 shares for services

2020-07-31 18:31 ET - News Release

Subject: Orion Nutraceuticals Inc. Word Document File: '\\doc\emailin\20200731 152640 Attachment 2020-07-31 News Release - Shares for Services.doc' 2 NEWS RELEASE Orion Nutraceuticals Announces Shares for Services Vancouver, British Columbia - July 31, 2020 - Orion Nutraceuticals Inc., (CSE: ORI) (the "Company" or "Orion") announces that it will issue 12,500 common shares of the Company (the "Shares") at a deemed price of $0.40 per Share to Mr. Sam Jenkins, a director of the Company, for certain consulting services provided to the Company owed totaling approximately $5,000. The Shares to be issued to Mr. Jenkins will be subject to a four-month hold period. About Orion Nutraceuticals Inc. Orion Nutraceuticals Inc. aims to set a new standard in cannabis life science by producing and developing innovative products with key strategic partners in the industry. In conjunction with its professional sports strategic alliances, the company is poised to advance research and development in the plant science sector, deliver science-based products and services, and market CBD therapies to the mainstream with proprietary brands and products. Orion shares trade in Canada on the CSE under the symbol ORI. ON BEHALF OF THE BOARD Joel Dumaresq, CEO and Director Tel: (604) 336-3195 The CSE and Information Service Provider have not reviewed and does not accept responsibility for the accuracy or adequacy of this release. This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties, which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's management's discussion and analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

© 2024 Canjex Publishing Ltd. All rights reserved.